RAPAE01 + amoxicillin + clarithromycin

This is a **combination drug** comprised of RAPAE01, amoxicillin, and clarithromycin. Amoxicillin and clarithromycin are both antibiotics frequently used together in the treatment of **Helicobacter pylori infection**, often as part of a triple or quadruple therapy. Their action involves cell wall synthesis inhibition (amoxicillin) and protein synthesis inhibition (clarithromycin), respectively. The precise identity and mechanism of RAPAE01 are not established in available references; therefore, no specific mechanism or indication beyond the context of combination antibiotic therapy for H. pylori can be assigned.